These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31982667)

  • 1. A multiple motion sensors index for motor state quantification in Parkinson's disease.
    Aghanavesi S; Westin J; Bergquist F; Nyholm D; Askmark H; Aquilonius SM; Constantinescu R; Medvedev A; Spira J; Ohlsson F; Thomas I; Ericsson A; Buvarp DJ; Memedi M
    Comput Methods Programs Biomed; 2020 Jun; 189():105309. PubMed ID: 31982667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motion Sensor-Based Assessment of Parkinson's Disease Motor Symptoms During Leg Agility Tests: Results From Levodopa Challenge.
    Aghanavesi S; Bergquist F; Nyholm D; Senek M; Memedi M
    IEEE J Biomed Health Inform; 2020 Jan; 24(1):111-119. PubMed ID: 30763248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a sensor algorithm for motor state rating in Parkinson's disease.
    Johansson D; Thomas I; Ericsson A; Johansson A; Medvedev A; Memedi M; Nyholm D; Ohlsson F; Senek M; Spira J; Westin J; Bergquist F
    Parkinsonism Relat Disord; 2019 Jul; 64():112-117. PubMed ID: 30935826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Treatment-Response Index From Wearable Sensors for Quantifying Parkinson's Disease Motor States.
    Thomas I; Westin J; Alam M; Bergquist F; Nyholm D; Senek M; Memedi M
    IEEE J Biomed Health Inform; 2018 Sep; 22(5):1341-1349. PubMed ID: 29989996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using measurements from wearable sensors for automatic scoring of Parkinson's disease motor states: Results from 7 patients.
    Ilias T; Filip B; Radu C; Dag N; Marina S; Mevludin M
    Annu Int Conf IEEE Eng Med Biol Soc; 2017 Jul; 2017():131-134. PubMed ID: 29059827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment.
    Senek M; Aquilonius SM; Askmark H; Bergquist F; Constantinescu R; Ericsson A; Lycke S; Medvedev A; Memedi M; Ohlsson F; Spira J; Westin J; Nyholm D
    Eur J Clin Pharmacol; 2017 May; 73(5):563-571. PubMed ID: 28101657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D Kinematics Quantifies Gait Response to Levodopa earlier and to a more Comprehensive Extent than the MDS-Unified Parkinson's Disease Rating Scale in Patients with Motor Complications.
    Barbosa R; Mendonça M; Bastos P; Pita Lobo P; Valadas A; Correia Guedes L; Ferreira JJ; Rosa MM; Matias R; Coelho M
    Mov Disord Clin Pract; 2024 Jul; 11(7):795-807. PubMed ID: 38610081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyskinesia estimation during activities of daily living using wearable motion sensors and deep recurrent networks.
    Hssayeni MD; Jimenez-Shahed J; Burack MA; Ghoraani B
    Sci Rep; 2021 Apr; 11(1):7865. PubMed ID: 33846387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of whole-body bradykinesia in Parkinson's disease participants using multiple inertial sensors.
    Memar S; Delrobaei M; Pieterman M; McIsaac K; Jog M
    J Neurol Sci; 2018 Apr; 387():157-165. PubMed ID: 29571855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous Assessment of Levodopa Response in Parkinson's Disease Using Wearable Motion Sensors.
    Pulliam CL; Heldman DA; Brokaw EB; Mera TO; Mari ZK; Burack MA
    IEEE Trans Biomed Eng; 2018 Jan; 65(1):159-164. PubMed ID: 28459677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Objective motion sensor assessment highly correlated with scores of global levodopa-induced dyskinesia in Parkinson's disease.
    Mera TO; Burack MA; Giuffrida JP
    J Parkinsons Dis; 2013 Jan; 3(3):399-407. PubMed ID: 23948993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Analysis of Bradykinesia and Rigidity in Parkinson's Disease.
    di Biase L; Summa S; Tosi J; Taffoni F; Marano M; Cascio Rizzo A; Vecchio F; Formica D; Di Lazzaro V; Di Pino G; Tombini M
    Front Neurol; 2018; 9():121. PubMed ID: 29568281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of levodopa on upper limb mobility and gait in Parkinson's disease.
    Vokaer M; Azar NA; de Beyl DZ
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1304-7. PubMed ID: 12933941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.
    Rosqvist K; Horne M; Hagell P; Iwarsson S; Nilsson MH; Odin P
    J Parkinsons Dis; 2018; 8(1):59-70. PubMed ID: 29480220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verification of a Method for Measuring Parkinson's Disease Related Temporal Irregularity in Spiral Drawings.
    Aghanavesi S; Memedi M; Dougherty M; Nyholm D; Westin J
    Sensors (Basel); 2017 Oct; 17(10):. PubMed ID: 29027941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study.
    Lopiano L; Modugno N; Marano P; Sensi M; Meco G; Cannas A; Gusmaroli G; Tamma F; Mancini F; Quatrale R; Costanzo AM; Gualberti G; Melzi G; di Luzio Paparatti U; Antonini A
    Neurol Sci; 2016 Nov; 37(11):1785-1792. PubMed ID: 27421834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locomotor response to levodopa in fluctuating Parkinson's disease.
    Moore ST; MacDougall HG; Gracies JM; Ondo WG
    Exp Brain Res; 2008 Feb; 184(4):469-78. PubMed ID: 17828529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pallidotomy and levodopa on walking and reaching movements in Parkinson's disease.
    Bastian AJ; Kelly VE; Perlmutter JS; Mink JW
    Mov Disord; 2003 Sep; 18(9):1008-17. PubMed ID: 14502668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor and non-motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel: final results of the GREENFIELD observational study.
    Lopiano L; Modugno N; Marano P; Sensi M; Meco G; Solla P; Gusmaroli G; Tamma F; Mancini F; Quatrale R; Zangaglia R; Bentivoglio A; Eleopra R; Gualberti G; Melzi G; Antonini A
    J Neurol; 2019 Sep; 266(9):2164-2176. PubMed ID: 31134377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.
    Warren Olanow C; Kieburtz K; Rascol O; Poewe W; Schapira AH; Emre M; Nissinen H; Leinonen M; Stocchi F;
    Mov Disord; 2013 Jul; 28(8):1064-71. PubMed ID: 23630119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.